Search

everythinglearnresearchcommunity

for

Search:↓

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Careful management of blood thinners is crucial for lupus patients with APS.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Researchers found four key proteins that affect the development of a specific hair type in Yangtze River Delta white goats.

A rare skin disorder, Ichthyosis with confetti, has no cure but treatment focuses on managing symptoms with moisturizers.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Steroids, infection management, and nutritional support can significantly improve symptoms of Cronkhite-Canada Syndrome.

Belimumab effectively controls SLE disease activity and reduces steroid use.